A2M Serves as Promising Biomarker for Chronic Obstructive Pulmonary Disease.

Xinru XiaoWei CaiZiqi DingYujia ShiLiang FanQian Zhang

Published in: International journal of chronic obstructive pulmonary disease (2023)

A2M is altered in peripheral blood of COPD patients and correlated with severity and infection. Moreover, there was no significant correlation between the change in A2M and smoking, FeNO and CaNO, suggesting A2M may reflect the overall rather than local inflammation in COPD patients and serve as a potential biomarker for nonsmoking COPD patients.

Keyphrases

chronic obstructive pulmonary disease
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
peripheral blood
prognostic factors
peritoneal dialysis
lung function
air pollution